Focal Epilepsy clinical trials

Explore recruiting focal epilepsy clinical trials.

Recruiting focal epilepsy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Focal Epilepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PET-MRI study of serotoninergic brainstem pathway in patients with Dravet Syndrome - DRAPETONINE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Bulgaria, Italy, Spain, Croatia, Portugal, Czechia +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of probenecid on cluster seizures during dosage reduction of Anti Seizure Medication (ASM) in presurgical focal epilepsy video-EEG monitoring

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

Portugal, Italy, Poland, France, Belgium, Spain +12 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Epiflux

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

Spain, Poland, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Focal Epilepsy trials by city

Focal Epilepsy in Toronto Focal Epilepsy in Vancouver Focal Epilepsy in Montreal Focal Epilepsy in Calgary Focal Epilepsy in Edmonton Focal Epilepsy in Ottawa Focal Epilepsy in Winnipeg Focal Epilepsy in Quebec City Focal Epilepsy in Hamilton Focal Epilepsy in Kitchener Focal Epilepsy in London Focal Epilepsy in Halifax Focal Epilepsy in New York Focal Epilepsy in Los Angeles Focal Epilepsy in Chicago Focal Epilepsy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease